lf 150195 has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirade, F; de Fornel, D; Ducoroy, P; Dutartre, P; Fontet, P | 1 |
| Atkins, RC; Dutartre, P; Hill, PA; Nikolic-Paterson, DJ; Tesch, GH; Wei, M | 1 |
2 other study(ies) available for lf 150195 and Disease Exacerbation
| Article | Year |
|---|---|
The immunosuppressant LF-150195 inhibits the progression of established collagen-induced arthritis by blockage of anticollagen IgG2a production.
Topics: Analysis of Variance; Animals; Antibody Formation; Arthritis, Experimental; Cattle; Collagen; Disease Progression; Enzyme-Linked Immunosorbent Assay; Guanidines; Immunoglobulin G; Immunoglobulin Idiotypes; Immunosuppressive Agents; Male; Mice; Mice, Inbred DBA; Time Factors | 2001 |
LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Disease Progression; Guanidines; Hypersensitivity, Delayed; Immunosuppressive Agents; Kidney; Male; Rats; Rats, Sprague-Dawley | 2001 |